4 completed, 1 withdrawn. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Withdrawn 1 |
Follow Triazolam: new trials by email Literature Review of Triazolam trials Research Report on Triazolam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Drug-drug Interaction Study With TS-172 in Healthy Adult Male Subjects Triazolam and TS-172, TS-172 and itraconazole - Healthy Male Subjects | Phase 1 | Completed | Taisho Pharmaceutical Co., Ltd. | 30 | 2025-03-11 | 2025-05-15 |
| A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants Esketamine, Placebo, Triazolam - Healthy | Phase 1 | Completed | Janssen Research & Development, LLC | 58 | 2012-12-01 | 2013-08-09 |
| A Study to Determine Whether an Oral Drops Formulation of Triazolam is Bioequivalent to a Tablet Formulation in Healthy Subjects triazolam liquid oral drops, triazolam tablets - Healthy | Phase 1 | Completed | Pfizer | 34 | 2011-09-01 | 2016-10-24 |
| Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption Triazolam - Healthy Volunteers | Phase 1 | Withdrawn | Pfizer | 2010-08-01 | 2016-04-06 | |
| Physiological, Behavioral and Subjective Effects of Drugs (GHB) sodium oxybate, triazolam and pentobarbital - Sedative Abuse | Phase 1 | Completed | Orphan Medical | 20 | 2003-08-01 | 2008-09-10 |
Pfizer (2) · Janssen Research & Development, LLC (1) · Orphan Medical (1) · Taisho Pharmaceutical Co., Ltd. (1)
Belgium (2) · Japan (1) · United States (1)